Latest Period
Q4 2025
Security Snapshot
Nanobiotix S.A. - Common Stock (NBTX) Institutional Ownership
CUSIP: 63009J107
13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026
Institutions Reporting
14
Shares (Excl. Options)
5,700,886
Price
$23.12
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- NBTX on Nasdaq
- Shares outstanding
- 46,821,220
- Price per share
- $32.00
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 5,700,886
- Total reported value
- $131,804,789
- % of total 13F portfolios
- 0%
- Share change
- +52,702
- Value change
- +$1,261,855
- Number of holders
- 14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- NBTX - Nanobiotix S.A. - Common Stock is tracked under CUSIP 63009J107.
- 14 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 14 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $131,804,789 to $25,560.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 14 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 63009J107?
CUSIP 63009J107 identifies NBTX - Nanobiotix S.A. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 63009J107:
Significant Owners of Nanobiotix S.A. - Common Stock (NBTX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 8.9% | $13,545,053 | 4,232,829 | Invus Public Equities, L.P. | 31 Dec 2023 | |||
| BAILLIE GIFFORD & CO | 4.1% | $6,142,944 | 1,919,670 | BAILLIE GIFFORD & CO | 31 Dec 2024 |
As of 31 Dec 2025, 14 institutional investors reported holding 5,700,886 shares of Nanobiotix S.A. - Common Stock (NBTX). This represents 12% of the company’s total 46,821,220 outstanding shares.
Top 16 Institutional Shareholders
The largest institutional shareholders of Nanobiotix S.A. - Common Stock (NBTX) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 12% | 5,623,816 | 0% | 23% | $130,022,626 |
| MORGAN STANLEY | 0.05% | 22,923 | +864% | 0% | $529,980 |
| MILLENNIUM MANAGEMENT LLC | 0.04% | 16,869 | 0% | $390,011 | |
| Optiver Holding B.V. | 0.03% | 16,225 | +203% | 0.01% | $375,122 |
| MARSHALL WACE, LLP | 0.02% | 9,500 | 0% | $219,641 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.01% | 3,600 | 0% | 0% | $83,232 |
| ROYAL BANK OF CANADA | 0.01% | 2,625 | +2000% | 0% | $61,000 |
| RHUMBLINE ADVISERS | 0.01% | 2,342 | +6997% | 0% | $54,141 |
| UBS Group AG | 0% | 1,530 | -29% | 0% | $35,374 |
| EverSource Wealth Advisors, LLC | 0% | 514 | 0% | 0% | $11,884 |
| OSAIC HOLDINGS, INC. | 0% | 500 | 0% | $11,560 | |
| GAMMA Investing LLC | 0% | 229 | 0% | $5,294 | |
| WELLS FARGO & COMPANY/MN | 0% | 200 | 0% | $4,624 | |
| NATIONAL BANK OF CANADA /FI/ | 0% | 13 | 0% | 0% | $300 |
| GEODE CAPITAL MANAGEMENT, LLC | 0% | 0 | -100% | $0 | |
| BARCLAYS PLC | 0% | 0 | -100% | $0 |
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 828 | $25,560 | +$18,491 | $30.87 | 1 |
| 2025 Q4 | 5,700,886 | $131,804,789 | +$1,261,855 | $23.12 | 14 |
| 2025 Q3 | 5,644,984 | $106,633,384 | +$3,288 | $18.89 | 11 |
| 2025 Q2 | 5,645,042 | $25,554,914 | -$414,807 | $4.73 | 8 |
| 2025 Q1 | 5,761,181 | $20,624,582 | -$1,004,115 | $3.58 | 10 |
| 2024 Q4 | 6,067,225 | $17,419,035 | -$1,000,406 | $2.87 | 16 |
| 2024 Q3 | 6,417,922 | $36,903,052 | -$14,323,739 | $5.75 | 9 |
| 2024 Q2 | 9,293,451 | $46,466,940 | -$68,645 | $5.00 | 11 |
| 2024 Q1 | 9,306,982 | $59,748,622 | +$230,299 | $6.50 | 11 |
| 2023 Q4 | 9,271,406 | $67,496,071 | +$33,478,773 | $7.28 | 12 |
| 2023 Q3 | 4,468,338 | $39,097,959 | +$8,789,679 | $8.75 | 9 |
| 2023 Q2 | 3,463,804 | $17,715,486 | +$5,090 | $5.07 | 5 |
| 2023 Q1 | 3,462,800 | $12,353,370 | -$3,852 | $3.52 | 4 |
| 2022 Q4 | 3,463,881 | $12,194,444 | +$2,929 | $3.67 | 5 |
| 2022 Q3 | 3,463,083 | $12,218,000 | -$49,000 | $3.54 | 5 |
| 2022 Q2 | 3,476,092 | $13,278,000 | -$18,904 | $3.78 | 6 |
| 2022 Q1 | 3,481,131 | $25,974,000 | -$293,544 | $7.25 | 6 |
| 2021 Q4 | 3,520,885 | $28,772,000 | -$6,268,938 | $8.10 | 7 |
| 2021 Q3 | 4,094,109 | $46,466,000 | -$10,429,241 | $11.36 | 9 |
| 2021 Q2 | 4,852,401 | $66,866,000 | -$203,431 | $13.78 | 10 |
| 2021 Q1 | 4,867,161 | $73,173,000 | -$987,342 | $15.04 | 10 |
| 2020 Q4 | 4,926,653 | $81,291,000 | +$81,291,000 | $16.50 | 11 |